Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
Hepatocellular carcinoma (HCC), which ranks globally as the third leading cause of cancer-related deaths, is highly prevalent, and most patients are diagnosed with advanced-stage cancer when treatments are largely ineffective. 1 Thus, there is an urgent need for earlier diagnosis to improve HCC patient outcomes.
